Cantitate/Preț
Produs

Psychiatric Drugs Explained

Autor David Healy
en Limba Engleză Paperback – 6 mai 2022
Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting.
Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.
A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.
Citește tot Restrânge

Preț: 16484 lei

Preț vechi: 23469 lei
-30% Nou

Puncte Express: 247

Preț estimativ în valută:
3155 3277$ 2620£

Carte disponibilă

Livrare economică 06-20 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 9176 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780702083907
ISBN-10: 0702083909
Pagini: 356
Ilustrații: 5 illustrations
Dimensiuni: 152 x 229 x 15 mm
Greutate: 0.57 kg
Ediția:7
Editura: Elsevier

Cuprins

Section 1 Management of the psychoses
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon